OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2022
(6)
2023
(3)
2021
(3)
2025
(2)
2017
(2)
2024
(1)
2020
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Decoupling of DNA methylation and activity of intergenic LINE-1 promoters in colorectal cancer.
Not available
S-EPMC5501206
|
biostudies-literature
Cite
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Not available
S-EPMC7032881
|
biostudies-literature
Cite
SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus.
Not available
S-EPMC9465152
|
biostudies-literature
Cite
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein.
Not available
S-EPMC10615762
|
biostudies-literature
Cite
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
Not available
S-EPMC5224719
|
biostudies-literature
Cite
Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients.
Not available
S-EPMC12618936
|
biostudies-literature
Cite
Global disparities in SARS-CoV-2 genomic surveillance.
Not available
S-EPMC9667854
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets